Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression : Results Through Week 144 of the SIMPL'HIV Trial
Contributors
Marinosci, AnnalisaPublished in
Open forum infectious diseases, vol. 11, no. 11, ofae618Publication date
2024-11First online date
2024-10-16Abstract
Keywords
- HIV-1 dual therapy
- Dolutegravir + emtricitabine
- Maintenance treatment
- Patient satisfaction
- Quality of life
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
MARINOSCI, Annalisa et al. Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression : Results Through Week 144 of the SIMPL’HIV Trial. In: Open forum infectious diseases, 2024, vol. 11, n° 11, p. ofae618. doi: 10.1093/ofid/ofae618
Main files (1)
Article (Published version)
Identifiers
- PID : unige:189372
- DOI : 10.1093/ofid/ofae618
- PMID : 39507885
- PMCID : PMC11540136
